Nature Genetics Highlights KFSH’s Integrated Genomic Medicine Model
The study reports that genomic testing increased by approximately 100% between 2022 and 2024, rising from around 22,000 tests to more than 44,000. Over the same period, the center completed more than 5,000 precision oncology analyses and activated pharmacogenomic alerts that altered treatment in 70% of documented cases. The rapid exome program alone generated savings equivalent to approximately SAR 15 million by reducing high cost interventions and shortening intensive care stays.
The article outlines how integrating four core tracks under unified institutional governance created an operational framework that helped correct prior misdiagnoses in approximately 80% of affected patients. These tracks include medical genomics, an internationally accredited precision medicine laboratory, AI driven computational sciences and translational genomics. This framework strengthened the connection between laboratory interpretation and clinical decision making.
The paper also notes that 23% of invasive prenatal tests identified targeted pathogenic variants, while 98% of families made decisions based on validated molecular findings. These results underscore genomic medicine’s expanding role in enabling early, evidence based health decisions.
Researchers report that KFSH contributed to the discovery of approximately 10% of disease associated genes and 20% of recessive disorders listed in Online Mendelian Inheritance in Man (OMIM), a leading global reference linking genes to hereditary conditions. The institution has also become the largest contributor from the Middle East to ClinVar, the database dedicated to the clinical interpretation of genetic variants, after submitting nearly 8,000 variants.
In addition, KFSH has documented close to 3,000 variants specific to Arab populations, 34% of which are not represented in the Genome Aggregation Database (gnomAD), thereby strengthening the representation of historically underrepresented populations in international genomic research.
Nature Genetics, published by the Nature Portfolio group, is one of the world’s most prestigious peer reviewed journals in genetics and genomics, recognized for rigorous editorial standards and for publishing research that shapes global directions in genomic medicine.
King Faisal Specialist Hospital has been ranked first in the Middle East and North Africa and 12th globally among the world’s top 250 Academic Medical Centers for 2026, and recognized as the most valuable healthcare brand in the Kingdom and the Middle East according to Brand Finance 2025. It has also been listed by Newsweek among the World’s Best Hospitals 2025, the World’s Best Smart Hospitals 2026, and the World’s Best Specialized Hospitals 2026.
Riyadh
KFSH
email us here
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
